Introduction

groups.
The clinical outcome of cardiac transplantation has markedly improved over the last two decades due to the introduction of cyclosporin therapy. However, the Long-term studies on renal function renal side-effects of cyclosporin appear to be a major drawback to its use. The early studies by Myers et al. In addition to the studies by Myers et al. [1] [2] [3] , seven [1] described the renal structural and functional retrospective long-term analyses and one case control changes in the native kidneys of heart transplant study regarding renal function in cardiac transplant recipients. Repeated haemodynamic investigations recipients have been published during the 1990s [4] [5] [6] [7] [8] [9] [10] . revealed a progressive decrease in glomerular filtration
These studies have shown that the renal function rate (GFR), a concomitant drop in renal plasma flow, post-transplant, determined either by serial measureand an increase in renal vascular resistance associated ments of serum creatinine or by regular clearance with systemic hypertension. Renal biopsies in a subset measurements, revealed a biphasic response with a of patients disclosed glomerulosclerosis, striped inter-rapid decline up to 12 months and a slower deteriorastitial fibrosis, and afferent arteriolopathy. In the ori-tion of renal function thereafter. A similar pattern of ginal study a high starting dose of cyclosporin was renal response was reported in 100 consecutive heartused (17 mg/kg), which was later decreased to lung transplant recipients [11] . The early loss of renal 10 mg/kg. However, when these two groups were com-function (within 12 months) apparently depends on pared, both of them had developed hypertension and the cyclosporin dose [1] and appears to be the key a decreased GFR. Even with a low dose of cyclosporin indicator of poor late outcome. Cyclosporin-induced the decline in GFR was approximately 45% from nephrotoxicity is characterized by an initially reversible baseline, as compared with historical controls treated decline in GFR, which is most probably caused by a with azathioprine and prednisone without cyclosporin. direct drug-induced afferent arteriolar vasoconstricPatients treated with low doses of cyclosporin had tion. The mechanisms underlying renal vasoconstricslightly lower mean serum (s-) creatinine concentra-tion and hypofiltration remain unknown, but tions, but similar pathological changes according to abnormalities in endogenous vasoconstrictor and vasorenal biopsies, than those treated with higher doses dilator mechanisms may be responsible [12] . In this [2, 3] . In addition, it was demonstrated that sequential respect, it is of interest to note that a single oral dose biopsies of the native kidney in the two cyclosporin of cyclosporin (5 mg/kg) caused a profound impairgroups revealed progressive histopathological changes. ment in renal haemodynamics. This was true for chronFurthermore there was an approximately 10% cumula-ically treated renal transplant patients [13] as well as tive incidence of end-stage renal disease during 10 for healthy volunteers in whom 10 mg/kg of cycloyears. The renal dysfunction could not be explained sporin resulted in an 18% decrease of GFR [14] .
The cyclosporin-induced increase in s-creatinine concentration may be associated with hypertension, a Correspondence and offprint requests to: Dr Hans Herlitz, Dept of disproportionate increase in s-urea concentration, Nephrology, Sahlgrenska University Hospital, S-41345, Gö teborg, Sweden.
hyperkalaemia, increased uric acid concentrations (due to decreased fractional excretion), mild proteinuria s-creatinine Á200 mmol/l during follow-up received a lower dose of cyclosporin than patients with serum (usually less than 1 g/24 h) and decreased fractional excretion of sodium. The blood pressure elevation creatinine <200 mmol/l.
In the two large studies by Zietse et al. [7] and could be associated with the decreased sodium excretion, stimulation of the renin-angiotensin system [15], Lindelö w et al. [10] there was, however, no relationship between the cyclosporin concentration and the decline increased local endothelin synthesis [16 ] , and/or reduction in local nitric oxide synthesis [17] . Although in renal function measured as the slope of s-creatinine vs time or by serial GFR measurements. Furthermore, withdrawal or dose reduction of cyclosporin may stabilize the renal function in some cases [18] , it is by no in the case control study by van Gelder et al. [20] cyclosporin dose and trough levels in the 24 patients means the rule [19] . Even if the renal function remains stable, proteinuria and morphological injury may still who developed renal insufficiency were not different from the patients who maintained their renal function. progress.
The deterioration of renal function in the seven This may indicate that cyclosporin nephrotoxicity is determined by individual susceptibility. studies mentioned above was conspicuous. The evolution of renal function after cardiac transplantation is
In the case control study it was also demonstrated that renal failure after heart transplantation was not shown in Table 1 . The mean s-creatinine values, pooled from all seven studies, are shown in Figure 1 . The limited to elderly patients with ischaemic heart disease, but also occurred in young patients having dilated most pronounced decrease in renal function was seen in the study by Greenberg et al. [4] where also the cardiomyopathy. This finding supported the observation by Zietse et al. [7] that no relationship could be highest doses of cyclosporin were used. The lowest cyclosporin doses were used in the study by Tinawi found between the decline in renal function posttransplant and the age at transplantation. On the other et al. [8] and no patient developed end-stage renal failure requiring dialysis. In their study, patients with hand, Greenberg et al. [4] and Lindelö w et al. [10] reported that high recipient age was an independent plasma flow were significantly depressed in these recipients. Light microscopy of autopsy specimens showed predictor of post-operative renal dysfunction. In the latter study it was also shown that the recipient age no structural renal abnormalities, either in patients without a history of renal disease or in patients who combined with GFR at 1 year post-transplantation predicted the development of severe dysfunction had died from dilated cardiomyopathy without a heart transplantation. However, arteriolopathy and glom-(<20 ml/min/1.73 m2). This occurred in 20% of the patients during 9 years follow-up. erulosclerosis were seen in the cyclosporin-treated patients. Thus, cyclosporin given for more than 2 years In three of the above-mentioned studies GFR was determined by means of iothalamate or Cr-EDTA induced moderate to severe renal failure associated with obliterative arteriolopathy and glomerular clearance measurements. Gonwa et al. [6 ] showed a 17% decrease in GFR during the first year post-ischaemia in all patients. During the development of cyclosporin nephropathy two sub-populations with transplant but no significant change occurred during 3 years. In the study by Goral et al. [9] no pre-operative glomeruli of abnormal size emerged; these comprised patients with (i) small glomeruli and global or seg-GFR was recorded, but between year 1 and year 7 there was no change in renal function. Lindelö w et al. mental sclerosis, and (ii) large glomeruli. In a followup study of these patients 2 years later a stabilization [10] found 21, 33 and 44% decrease in GFR 1, 5 and 9 years after transplantation respectively.
of GFR and renal plasma flow was noted but at that time no histopathology was recorded [24] . In none of the seven studies did any other parameter such as renal function before transplantation, blood Many short-term studies have shown surprisingly good renal function 1 year after heart transplantation, pressure, or treatment with specific antihypertensive drugs show a correlation to the decline in renal function yet renal dysfunction may appear later with proteinuria and progressive, mostly irreversible, histological after transplantation. Patients with renal insufficiency before transplantation and those with a more pro-lesions.
There is a dissociation between progressive tubuloinnounced depression of renal function at 6 months posttransplantation had a high risk for progressive kidney terstitial and arteriolar disease on the one hand and renal function on the other. Experimental studies of failure after heart transplantation, according to the study by Sehgal et al. [21] . The patients who developed cyclosporin nephropathy have found that GFR returned to normal 1 month after the discontinuation renal insufficiency were older than those who did not. Contrary to this report, Goral et al. [9] demonstrated of cyclosporin therapy, whereas tubulointerstitial pathology persisted [25] . Such dissociation may reflect that patients with an initial post-transplantation GFR <60 ml/min/1.73m2 had a stable renal function during differences in pathogenesis, since Kon et al. [26 ] showed that haemodynamic changes after cyclosporin the follow-up period. Lindelö w et al. (unpublished observation) found that patients with a baseline GFR therapy can be inhibited by endothelin antagonists, whereas ACE inhibitors reduce fibrosis. In animal ∏66 ml/min/1.73 m2 had a reduced decrease in renal function as compared to those with GFR models of cyclosporin nephrotoxicity, both angiotensin II and endothelin seemed to play roles in the renal >66 ml/min/1.73 m2.
As shown in Table 1 , the development of end-stage injury. Blockade of the renin-angiotensin system protected the kidneys from morphological vascular and renal failure requiring renal replacement therapy was 2-4% during a 4-7-year follow-up in six out of seven tubulointerstitial injury, but without any effect on the decline in GFR [27] . On the other hand, endothelin studies. The corresponding figures for the large Stanford . These 8% respectively. data suggest that angiotensin II, but not endothelin, may participate in the cyclosporin-induced fibrosis.
Cyclosporin-induced renal injury
Calcium antagonists are potent vasodilators of the afferent arteriole and have been demonstrated to reduce the acute cyclosporin nephrotoxicity [28, 29] . In human No significant correlation has been described between the cyclosporin dose or blood concentration and the studies, no convincing favourable effect of blockade of the renin-angiotensin system on post-transplant renal initial remarkable decline in renal function posttransplant revealed in any of the studies. There is failure has been described. However, at least three studies have disclosed a positive effect of calcium consensus that the drug is responsible for the renal injury, since irreversible loss of renal function has been antagonists in heart transplant recipients in this respect [30] [31] [32] . The effect of endothelin antagonists on the reported even with low doses of cyclosporin after liver, pancreas, and bone marrow transplantation, and also evolution of renal function in transplant recipients remains to be studied. in patients with uveitis, insulin-dependent diabetes, rheumatoid arthritis, and psoriasis.
Bertani et al.
[23] performed an important study
Preventive measures
where renal biopsies were obtained at the same time as the renal haemodynamics were measured in 10 heart transplant recipients who had been on low-dose cyclo-Except for a possible favourable effect from calciumchannel blockers on preventing or reversing the sporin therapy for more than 2 years. GFR and renal consecutive heart-lung transplant recipients. Am J Kidney Dis nephrotoxic effects of cyclosporin after cardiac trans- 1995; 26: 643-648 plantation, there are no known treatments that are 12. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. uniformly effective in heart and renal transplant recipi- 
